Clear Data. Clear Impact.
CDISC (cdisc.org) scores 77 out of 100 on Brand Analyzer, placing it in the Brand-Ready tier among Healthcare brands, Non-profit brands, Education brands, in the 57th percentile of 18382 Healthcare brands.
CDISC (Clinical Data Interchange Standards Consortium) is a global non-profit organization founded in 1999 that develops and maintains data standards for clinical research. Its standards support consistent collection, exchange, submission, and archiving of clinical trial data, improving data quality and interoperability across the healthcare and life sciences sectors. CDISC's work is used by pharmaceutical companies, clinical researchers, regulatory agencies, and healthcare organizations worldwide to streamline clinical trial processes and support regulatory submissions.
| Brand Name | CDISC |
|---|---|
| Domain | cdisc.org |
| Industry | Healthcare, Non-profit |
| Founded | 1999 |
| Headquarters | Bordeaux |
| Parent Company / Owner | Cnova |
| Main Competitors | HL7 International (78/100), PhUSE, TransCelerate BioPharma (75/100), SNOMED International (84/100), Regenstrief Institute (LOINC) (84/100) |
Moz Domain Authority 51/100 vs category average 40 / leader 97 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
Ranked #201,656 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "CDISC works to develop and advance data standards that amplify the impact of clinical research data." (No meta description) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: canonical. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Nginx, Drupal.
Social footprint: verified profiles on Facebook, YouTube, X (Twitter), LinkedIn, Instagram, GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked October 2026.
When asked "What is CDISC?", Claude could identify the brand as of October 2026. CDISC (Clinical Data Interchange Standards Consortium) is a nonprofit organization that develops and maintains global standards for the collection, exchange, and submission of clinical research data. Its standards, like SDTM, ADaM, and CDASH, are widely required by regulatory age Best known for Developing standardized data formats (SDTM, ADaM, CDASH) used for clinical trial data submission to regulators like the FDA.
When asked "Best brands similar to CDISC?", Claude would recommend CDISC as of October 2026. It's the de facto standard-setting body in clinical research data, so anyone working in clinical trials or pharma data management would need to know about it.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
CDISC's main competitors in Healthcare: HL7 International (78/100), TransCelerate BioPharma (75/100), SNOMED International (84/100), Regenstrief Institute (LOINC) (84/100).
Sources: Brand Analyzer scan
CDISC has limited AI-search visibility, scoring 35/100 on Brand Analyzer's AI visibility composite (visibility 30, trust 26, recommendation 53). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: CDISC official site
CDISC was founded in 1999. CDISC operates in the Healthcare category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
CDISC is headquartered in Bordeaux. CDISC operates in the Healthcare category.
Sources: Wikidata
CDISC scores 53/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: CDISC official site
CDISC (Clinical Data Interchange Standards Consortium) is a global, non-profit standards development organization founded in 1999 that focuses on clinical research data. It creates and maintains data standards intended to make clinical trial data more consistent, interoperable, and usable across the pharmaceutical, biotech, and regulatory sectors.
Sources: CDISC official site
CDISC develops and advances data standards for clinical research, including foundational and therapeutic area-specific standards. These standards define how clinical trial data should be structured, collected, and submitted, supporting consistency and interoperability between sponsors, researchers, and regulatory bodies such as health authorities reviewing clinical trial submissions.
Sources: CDISC official site
CDISC can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: CDISC official site
CDISC offers data standards for clinical research, including end-to-end foundational and therapeutic area-specific standards. These cover areas such as data collection, tabulation, and submission formats intended to support consistent and interoperable handling of clinical trial data throughout the research and regulatory review process.
Sources: CDISC official site
CDISC is owned by or part of Cnova. CDISC operates in the Healthcare category.
Sources: Wikidata
CDISC standards are used by clinical researchers, pharmaceutical and biotech companies, regulatory bodies, and healthcare organizations involved in designing, conducting, and submitting clinical trials. These groups rely on CDISC standards to ensure that clinical trial data is structured consistently and can be shared or reviewed across different systems and institutions.
Sources: CDISC official site
CDISC is known for creating globally recognized clinical research data standards, such as standards for data collection, tabulation, and submission formats used throughout the clinical trial lifecycle. These standards are widely referenced by pharmaceutical companies and regulatory agencies for organizing and exchanging clinical trial data.
Sources: CDISC official site
CDISC scores 35/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
CDISC has a weak AI-visibility profile at 35/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (53/100) and its weakest is trust (26/100). It benefits from a Wikidata knowledge-graph entry, a global traffic rank of #201,656 (Tranco) and a Moz Domain Authority of 51/100. The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, thin schema.org structured data and no llms.txt to steer AI to its best pages. In a live check, Claude could already identify CDISC from memory (October 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to CDISC: Catholic Community Services of Western Washington (77/100), CBI Health (77/100), CellPath (77/100), Celo (77/100).
A step up - brands to learn from: Zymo Research (81/100), Zurich Insurance Group (81/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.